» Articles » PMID: 29618899

Hypothetical Endogenous SIV-like Antigens in Mauritian Cynomolgus Macaques

Overview
Journal Bioinformation
Specialty Biology
Date 2018 Apr 6
PMID 29618899
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Simian immunodeficiency virus (SIV) infection of Mauritian cynomolgus macaques (MCMs) is an increasingly important nonhuman primate model for HIV vaccine research. We previously reported that in MCMs anti-SIV antibodies can be naturally developed without exogenous infection or vaccination, and that a vaccine targeting SIV protease cleavage sites (PCS) can cross-induce antibodies to non-PCS SIV antigens. We speculate that this is potentially caused by the existence of endogenous SIV-like antigens. External stimuli (such as environmental factors and vaccination) may induce expression of endogenous SIV-like antigens to elicit these antibodies. Database and mass spectrometry analyses were conducted to search for such antigens. We identified endogenous SIV-like DNA sequences in cynomolgus macaque genome and non-PCS peptide homologous to SIV Env protein in PBMCs of a PCS-vaccinated monkey. Our preliminary insights suggest that endogenous SIV-like antigens may be one of the possible reasons for the natural and cross-inducible SIV antibodies in MCMs.

Citing Articles

Toll-like Interleukin -1 Receptor Regulator (TILRR) Protein, a Major Modulator of Inflammation, is Expressed in Normal Human and Macaque Tissues and PBMCs.

Abul Kashem M, Li L, Yuan X, Plummer F, Luo M J Inflamm Res. 2022; 15:2925-2937.

PMID: 35592073 PMC: 9113122. DOI: 10.2147/JIR.S357866.


Viruses and Evolution - Viruses First? A Personal Perspective.

Moelling K, Broecker F Front Microbiol. 2019; 10:523.

PMID: 30941110 PMC: 6433886. DOI: 10.3389/fmicb.2019.00523.


Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.

Li H, Hai Y, Lim S, Toledo N, Crecente-Campo J, Schalk D PLoS One. 2018; 13(8):e0202997.

PMID: 30153293 PMC: 6112674. DOI: 10.1371/journal.pone.0202997.

References
1.
Tandon R, SenGupta D, Ndhlovu L, Vieira R, Jones R, York V . Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects. J Virol. 2011; 85(21):11526-31. PMC: 3194955. DOI: 10.1128/JVI.05418-11. View

2.
Yan G, Zhang G, Fang X, Zhang Y, Li C, Ling F . Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques. Nat Biotechnol. 2011; 29(11):1019-23. DOI: 10.1038/nbt.1992. View

3.
Paces J, Huang Y, Paces V, Ridl J, Chang C . New insight into transcription of human endogenous retroviral elements. N Biotechnol. 2012; 30(3):314-8. DOI: 10.1016/j.nbt.2012.11.009. View

4.
Chen Y, Wang S, Lu S . DNA Immunization for HIV Vaccine Development. Vaccines (Basel). 2015; 2(1):138-59. PMC: 4494200. DOI: 10.3390/vaccines2010138. View

5.
van der Kuyl A . HIV infection and HERV expression: a review. Retrovirology. 2012; 9:6. PMC: 3311604. DOI: 10.1186/1742-4690-9-6. View